Bio-Rad Laboratories Quick Ratio 2010-2024 | BIO
Historical quick ratio values for Bio-Rad Laboratories (BIO) over the last 10 years.
| Bio-Rad Laboratories Quick Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
| 2024-12-31 | $2.27B | $0.47B | 4.85 |
| 2024-09-30 | $2.25B | $0.50B | 4.52 |
| 2024-06-30 | $2.25B | $0.49B | 4.63 |
| 2024-03-31 | $2.28B | $0.47B | 4.89 |
| 2023-12-31 | $2.27B | $0.52B | 4.34 |
| 2023-09-30 | $2.37B | $0.56B | 4.25 |
| 2023-06-30 | $2.36B | $0.58B | 4.06 |
| 2023-03-31 | $2.52B | $0.59B | 4.28 |
| 2022-12-31 | $2.44B | $0.57B | 4.29 |
| 2022-09-30 | $2.45B | $0.57B | 4.30 |
| 2022-06-30 | $2.59B | $0.61B | 4.22 |
| 2022-03-31 | $2.70B | $0.65B | 4.16 |
| 2021-12-31 | $1.42B | $0.68B | 2.08 |
| 2021-09-30 | $1.88B | $0.65B | 2.89 |
| 2021-06-30 | $1.69B | $0.59B | 2.88 |
| 2021-03-31 | $1.57B | $0.61B | 2.57 |
| 2020-12-31 | $1.52B | $0.63B | 2.40 |
| 2020-09-30 | $1.68B | $0.99B | 1.71 |
| 2020-06-30 | $1.50B | $0.93B | 1.62 |
| 2020-03-31 | $1.53B | $0.87B | 1.76 |
| 2019-12-31 | $1.63B | $0.91B | 1.80 |
| 2019-09-30 | $1.46B | $0.43B | 3.36 |
| 2019-06-30 | $1.50B | $0.45B | 3.36 |
| 2019-03-31 | $1.44B | $0.44B | 3.24 |
| 2018-12-31 | $1.44B | $0.45B | 3.19 |
| 2018-09-30 | $1.43B | $0.45B | 3.16 |
| 2018-06-30 | $1.40B | $0.44B | 3.17 |
| 2018-03-31 | $1.37B | $0.46B | 2.99 |
| 2017-12-31 | $1.38B | $0.50B | 2.75 |
| 2017-09-30 | $1.29B | $0.47B | 2.77 |
| 2017-06-30 | $1.25B | $0.46B | 2.74 |
| 2017-03-31 | $1.17B | $0.41B | 2.88 |
| 2016-12-31 | $1.32B | $0.47B | 2.80 |
| 2016-09-30 | $1.29B | $0.44B | 2.92 |
| 2016-06-30 | $1.26B | $0.41B | 3.08 |
| 2016-03-31 | $1.24B | $0.40B | 3.10 |
| 2015-12-31 | $1.29B | $0.44B | 2.92 |
| 2015-09-30 | $1.28B | $0.44B | 2.95 |
| 2015-06-30 | $1.24B | $0.40B | 3.07 |
| 2015-03-31 | $1.22B | $0.42B | 2.94 |
| 2014-12-31 | $1.25B | $0.45B | 2.79 |
| 2014-09-30 | $1.25B | $0.50B | 2.48 |
| 2014-06-30 | $1.25B | $0.48B | 2.60 |
| 2014-03-31 | $1.25B | $0.48B | 2.60 |
| 2013-12-31 | $1.24B | $0.49B | 2.55 |
| 2013-09-30 | $1.15B | $0.46B | 2.49 |
| 2013-06-30 | $1.42B | $0.43B | 3.29 |
| 2013-03-31 | $1.40B | $0.45B | 3.13 |
| 2012-12-31 | $1.48B | $0.47B | 3.14 |
| 2012-09-30 | $1.39B | $0.43B | 3.20 |
| 2012-06-30 | $1.36B | $0.42B | 3.26 |
| 2012-03-31 | $1.35B | $0.44B | 3.05 |
| 2011-12-31 | $1.37B | $0.46B | 2.97 |
| 2011-09-30 | $1.43B | $0.42B | 3.45 |
| 2011-06-30 | $1.44B | $0.44B | 3.25 |
| 2011-03-31 | $1.37B | $0.43B | 3.20 |
| 2010-12-31 | $1.58B | $0.67B | 2.37 |
| 2010-09-30 | $1.25B | $0.41B | 3.04 |
| 2010-06-30 | $1.19B | $0.39B | 3.04 |
| 2010-03-31 | $1.16B | $0.40B | 2.92 |
| 2009-12-31 | $1.21B | $0.42B | 2.89 |
| 2009-09-30 | $1.12B | $0.42B | 2.69 |
| 2009-06-30 | $1.02B | $0.38B | 2.66 |
| 2009-03-31 | $0.68B | $0.36B | 1.91 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $6.618B | $2.567B |
| Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.007B | 27.90 |
| Boston Scientific (BSX) | United States | $155.135B | 38.84 |
| Stryker (SYK) | United States | $149.698B | 31.30 |
| EssilorLuxottica (ESLOY) | France | $129.877B | 0.00 |
| Medtronic (MDT) | Ireland | $110.440B | 16.12 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.984B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.101B | 27.36 |
| ResMed (RMD) | United States | $36.449B | 27.38 |
| GE HealthCare Technologies (GEHC) | United States | $33.384B | 15.85 |
| Agilent Technologies (A) | United States | $32.046B | 21.17 |
| Terumo (TRUMY) | Japan | $27.153B | 35.27 |
| Koninklijke Philips (PHG) | Netherlands | $22.822B | 16.41 |
| Insulet (PODD) | United States | $22.662B | 88.96 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.138B | 12.29 |
| Baxter (BAX) | United States | $15.929B | 11.89 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.591B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.030B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.520B | 13.92 |
| Prestige Consumer Healthcare (PBH) | United States | $4.305B | 19.23 |
| Perrigo (PRGO) | Ireland | $3.614B | 9.16 |
| Haemonetics (HAE) | United States | $3.485B | 15.18 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.459B | 25.51 |
| Envista Holdings (NVST) | United States | $3.066B | 25.48 |
| QuidelOrtho (QDEL) | United States | $2.234B | 15.36 |
| GN Store Nord (GNNDY) | Denmark | $2.150B | 17.81 |
| LeMaitre Vascular (LMAT) | United States | $1.882B | 42.07 |
| AtriCure (ATRC) | United States | $1.599B | 0.00 |
| Neogen (NEOG) | United States | $1.424B | 18.22 |
| AdaptHealth (AHCO) | United States | $1.220B | 12.38 |
| Kestra Medical Technologies (KMTS) | United States | $1.220B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.209B | 27.19 |
| BioLife Solutions (BLFS) | United States | $1.045B | 0.00 |
| InMode (INMD) | Israel | $1.023B | 9.37 |
| Phibro Animal Health (PAHC) | United States | $0.966B | 12.35 |
| Evolus (EOLS) | United States | $0.645B | 0.00 |
| CeriBell (CBLL) | United States | $0.636B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.586B | 0.00 |
| Owens & Minor (OMI) | United States | $0.548B | 4.54 |
| Valneva SE (VALN) | France | $0.516B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.499B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.443B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.437B | 0.00 |
| Surmodics (SRDX) | United States | $0.401B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.354B | 0.00 |
| SNDL (SNDL) | Canada | $0.336B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.325B | 11.95 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.279B | 49.60 |
| Sanara MedTech (SMTI) | United States | $0.274B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.271B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.268B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.266B | 22.47 |
| Cerus (CERS) | United States | $0.247B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.246B | 0.00 |
| ZimVie (ZIMV) | United States | $0.242B | 11.00 |
| Omeros (OMER) | United States | $0.230B | 0.00 |
| Biote (BTMD) | United States | $0.220B | 6.18 |
| Brainsway (BWAY) | Israel | $0.188B | 49.90 |
| High Tide (HITI) | Canada | $0.187B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.184B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.180B | 14.51 |
| Quanterix (QTRX) | United States | $0.175B | 0.00 |
| Organigram Global (OGI) | Canada | $0.166B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.165B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 16.72 |
| Jin Medical (ZJYL) | China | $0.129B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.128B | 0.00 |
| Exagen (XGN) | United States | $0.122B | 0.00 |
| MacroGenics (MGNX) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| Fonar (FONR) | United States | $0.084B | 10.83 |
| Veru (VERU) | United States | $0.075B | 0.00 |
| Agape ATP (ATPC) | $0.075B | 0.00 | |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.067B | 0.00 |
| Zynex (ZYXI) | United States | $0.066B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.065B | 0.00 |
| United Health Products (UEEC) | United States | $0.064B | 0.00 |
| Apyx Medical (APYX) | United States | $0.056B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.052B | 0.00 |
| ImmuCell (ICCC) | United States | $0.048B | 0.00 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.00 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Safety Shot (SHOT) | United States | $0.031B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 30.57 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.019B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |